Praxis Precision Med Is Maintained at Outperform by Oppenheimer

Dow Jones14:18 ET · Ratings

Praxis Precision Medicine Analyst Ratings

Benzinga13:05 ET · Ratings

Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $163

Moomoo NewsOct 31 08:31 ET · Ratings

Dignify Therapeutics Selected as a Praxis SCI Accelerate Company

PR NewswireOct 22 06:00 ET

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate

Yahoo FinanceOct 21 10:10 ET

AlphaTrAI Rebrands as Praxis Solutions to Deliver Integrated Technology Solutions to Marketplace

PR NewswireOct 15 06:00 ET